Cytophage Technologies Inc. announced that it has signed a letter of intent for private placement of equity securities for gross proceeds of a minimum of $3,000,000 and a maximum of $5,000,000 on June 1, 2023. The transaction included participation from new investor, Cuspis Capital III Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 CAD | +6.52% | +2.08% | -30.46% |
05-27 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
04-30 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.46% | 15.37M | |
+40.73% | 739B | |
+31.59% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.62% | 240B | |
+9.46% | 210B | |
-4.91% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CYTO Stock
- News Cytophage Technologies Ltd.
- Cytophage Technologies Inc. announced that it expects to receive $5 million in funding from Cuspis Capital III Ltd.